spacer
home > ebr > spring 2019 > the authenticity of synthetics
PUBLICATIONS
European Biopharmaceutical Review

The Authenticity of Synthetics

Synthetic biology is a newly coined term for the design and construction of novel artificial biological pathways, organisms, or devices or the redesign of existing natural biological systems (1). Generally, it assumes an element of scale and the application of engineering-like techniques to solve biological problems through a rational process of ‘biodesign’. The field of synthetic biology brings together skills from biology and chemistry to computing, bioinformatics, and engineering. This emerging field is greatly anticipated to deliver significant and broad impact across a range of potential applications, among them the drug discovery and development field. However, to achieve its full potential, synthetic biology will require the continued development and convergence of its underlying skills and disciplines to enable the rational and predictable design of biological systems. As DNA is a fundamental building block of synthetic biology, the key to its success will be the ability to synthesise DNA at scale and with high accuracy.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Tim Brears is CEO at Evonetix, where he leads the company in developing a benchtop DNA writer to transition DNA synthesis from a service industry to one where scientists can make genes at will. He holds a PhD from the University of Cambridge, UK, and has an MBA from Duke University’s Fuqua School of Business, US.
spacer
Dr Tim Brears
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase

AirBridgeCargo expands its passive pharma solutions in partnership with SkyCell as it achieves the two-fold volume increase AirBridgeCargo Airlines (ABC), one of the leaders in transportation of pharmaceutical products by air, and Zurich-based cold-chain ULD manufacturer SkyCell have sealed their partnership for the lease of all types of SkyCell containers to meet the demand for evolving volumes of passive pharmaceutical shipments, which reached around 3,500 tonnes for 1Q 2019 YOY and demonstrated a two-fold increase.
More info >>

White Papers

Preparation of Pharmaceutical Samples for Metals Analysis

RSSL

There has been a lot of discussion regarding the methods of analysis for pharmaceutical products as we await the upcoming changes to both the EP and USP, relating to the analysis of metal impurities.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement